why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: June 29, 2025

Clinical Trial: Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetes Mellitus Type 2

Study Type: OBSERVATIONAL


Official Title: Sex Related Outcomes in Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus: A 12-month Real-world Study

Brief Summary: This real-world, comparative cohort study aims to evaluate the 12-month effectiveness of oral versus subcutaneous semaglutide in patients with type 2 diabetes mellitus (T2D), with a specific focus on sex-based differences in metabolic response.A total of 212 patients were enrolled and evenly assigned to either oral or subcutaneous semaglutide.The primary outcome was the change in HbA1c, while secondary outcomes included variations in weight, lipid profile, liver function, and hepatic steatosis index.Subcutaneous…

Read more